Sign in to fuzzto save your conversations, follow your research and come back anytime.
Pine Labs
SectorFinancial Services
In the news
NPCI defers UPI MDR implementation post-Diwali amid legal challenges
Pine Labs extends five-year tech partnership with Woolworths Group
Mastercard's Pine Labs Exit: What the Rs 933 Crore Deal Really Means
Mastercard Exits Pine Labs, Sells 4.31% Stake for ₹934 Cr
FTSE Rebalancing: What It Means for India's New Market Entrants
Paytm, Pine Labs shares rally as JPMorgan upgrades after MDR
Small banks partner with fintechs for merchant payment control
Pine Labs appoints Jayaram Karthik as COO amid strong Q1 results
Alpha Wave completes ₹550 cr Pine Labs exit with major institutional buyers
Pine Labs shares surge 4% on Investec's ₹200 target, 20% upside potential
Pine Labs' Breakage Income Problem: A ₹113 Crore Profit at Risk
Company insights, generated from the most recent coverage.
Pine Labs has no consumer UPI app, so it can only claim the acquiring-side share of MDR set through bank agreements — it structurally misses the fixed TPAP slice that Paytm captures, making its take wholly dependent on bank negotiation.
With top-10 customers at ~29-31% of revenue and an enterprise/mid-market skew, Pine Labs faces concentrated merchant pushback on MDR pass-through — fewer, larger counterparties mean each one carries real negotiating leverage against it.
Pine Labs posts the highest EBITDA margin of the three at 12.4%, but on Q1 FY27 net profit of just ₹19.6 Cr that cushion is thin — margin leadership does not translate into much absolute profit buffer against compression.